Skip to main content
Erschienen in: Supportive Care in Cancer 4/2020

02.08.2019 | Original Article

Clinical and sociodemographic factors that affect the quality of life of survivors of head and neck cancer

verfasst von: Laura Izabel Lampert Bonzanini, Eloisa Barbieri Soldera, Gabriela Barbieri Ortigara, Riéli Elis Schulz, Raquel Pippi Antoniazzi, Thiago Machado Ardenghi, Kívia Linhares Ferrazzo

Erschienen in: Supportive Care in Cancer | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Objective

The present cross-sectional study evaluated the quality of life of patients treated with 3-D conformal radiotherapy for cancer of the mouth, oropharynx, hypopharynx, or larynx and investigated possible associations with clinical and sociodemographic variables using multivariate analysis.

Methods

The sample was composed of 90 patients who had completed treatment at least 3 months earlier. Data were collected from April 2016 to May 2017. The patients were clinically evaluated with regard to stimulated salivary flow, trismus, and radiation caries. Sociodemographic data and data related to the disease (stage, location of primary tumor, and radiation dose) were collected from the patient charts. Quality of life was assessed using the Brazilian version of the University of Washington Quality of Life (UW-QOL) questionnaire. Poisson logistic regression was performed to determine the mean ratio and test associations with the clinical and sociodemographic variables.

Results

The mean total of the UW-QOL was 814.88 (± 224.58). Patient age, staging of cancer, hyposalivation, and trismus were associated with quality of life. Patients with tumors in the advanced stage, those with hyposalivation and those with trismus respectively had 11% (CI 0.80–0.98), 12% (CI 0.79–0.99), and 15% (CI 0.77–0.94) lower UW-QOL scores, indicating poorer quality of life.

Conclusion

Survivors of head and neck cancer experience a negative impact on quality of life associated with trismus, hyposalivation, advanced stage tumors, and a younger patient age. The present findings underscore the importance of a specific approach focused on these aspects to ensure better quality of life in the long term.
Literatur
5.
Zurück zum Zitat Andrade FP, Biazevic MG, Toporcov TN, Togni J, de Carvalho MB (2012) Discriminant validity of the University of Washington quality of life questionnaire in the Brazilian context. Rev Bras Epidemiol 15(4):781–789CrossRef Andrade FP, Biazevic MG, Toporcov TN, Togni J, de Carvalho MB (2012) Discriminant validity of the University of Washington quality of life questionnaire in the Brazilian context. Rev Bras Epidemiol 15(4):781–789CrossRef
12.
Zurück zum Zitat Rogers SN, Gwanne S, Lowe D, Humphris G, Yueh B, Weymuller EA (2002) The addition of mood and anxiety domains to the University of Washington quality of life scale. Head Neck 24(6):521–529CrossRef Rogers SN, Gwanne S, Lowe D, Humphris G, Yueh B, Weymuller EA (2002) The addition of mood and anxiety domains to the University of Washington quality of life scale. Head Neck 24(6):521–529CrossRef
16.
Zurück zum Zitat Navazesh M, Kumar SK (2008) University of Southern California School of Dentistry. Measuring salivary flow: challenges and opportunities. J Am Dent Assoc 139(Suppl):35S–40SCrossRef Navazesh M, Kumar SK (2008) University of Southern California School of Dentistry. Measuring salivary flow: challenges and opportunities. J Am Dent Assoc 139(Suppl):35S–40SCrossRef
18.
Zurück zum Zitat Sreebny LM (2000) Saliva in health and disease: an appraisal and update. Int Dent J 50(3):140–161CrossRef Sreebny LM (2000) Saliva in health and disease: an appraisal and update. Int Dent J 50(3):140–161CrossRef
19.
Zurück zum Zitat Reisine S, Morse DE, Psoter WJ, Eisenberg E, Cohen D, Cleveland D, Mohit-Tabatabai M (2005) Sociodemographic risk indicators for depressive symptoms among persons with oral cancer or oral epithelial dysplasia. J Oral Maxillofac Surg 63(4):513–520CrossRef Reisine S, Morse DE, Psoter WJ, Eisenberg E, Cohen D, Cleveland D, Mohit-Tabatabai M (2005) Sociodemographic risk indicators for depressive symptoms among persons with oral cancer or oral epithelial dysplasia. J Oral Maxillofac Surg 63(4):513–520CrossRef
23.
Zurück zum Zitat Sroussi HY, Epstein JB, Bensadoun RJ, Saunders DP, Lalla RV, Migliorati CA, Heaivilin N, Zumsteg ZS (2017) Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis. Cancer Med 6(12):2918–2931. https://doi.org/10.1002/cam4.1221 CrossRefPubMedPubMedCentral Sroussi HY, Epstein JB, Bensadoun RJ, Saunders DP, Lalla RV, Migliorati CA, Heaivilin N, Zumsteg ZS (2017) Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis. Cancer Med 6(12):2918–2931. https://​doi.​org/​10.​1002/​cam4.​1221 CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Almståhl A, Skoogh Andersson J, Alstad T, Fagerberg-Mohlin B, Finizia C (2018) Explorative study on quality of life in relation to salivary secretion rate in head and neck cancer patients treated with radiotherapy up to 2 years post treatment. Int J Dent Hyg 16. https://doi.org/10.1111/idh.12363 CrossRef Almståhl A, Skoogh Andersson J, Alstad T, Fagerberg-Mohlin B, Finizia C (2018) Explorative study on quality of life in relation to salivary secretion rate in head and neck cancer patients treated with radiotherapy up to 2 years post treatment. Int J Dent Hyg 16. https://​doi.​org/​10.​1111/​idh.​12363 CrossRef
28.
Zurück zum Zitat Likhterov I, Ru M, Ganz C, Urken ML, Chai R, Okay D, Liu J, Stewart R, Culliney B, Palacios D, Lazarus CL (2018) Objective and subjective hyposalivation after treatment for head and neck cancer: long-term outcomes. Laryngoscope 16:2732–2739. https://doi.org/10.1002/lary.27224 CrossRef Likhterov I, Ru M, Ganz C, Urken ML, Chai R, Okay D, Liu J, Stewart R, Culliney B, Palacios D, Lazarus CL (2018) Objective and subjective hyposalivation after treatment for head and neck cancer: long-term outcomes. Laryngoscope 16:2732–2739. https://​doi.​org/​10.​1002/​lary.​27224 CrossRef
Metadaten
Titel
Clinical and sociodemographic factors that affect the quality of life of survivors of head and neck cancer
verfasst von
Laura Izabel Lampert Bonzanini
Eloisa Barbieri Soldera
Gabriela Barbieri Ortigara
Riéli Elis Schulz
Raquel Pippi Antoniazzi
Thiago Machado Ardenghi
Kívia Linhares Ferrazzo
Publikationsdatum
02.08.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 4/2020
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-05008-4

Weitere Artikel der Ausgabe 4/2020

Supportive Care in Cancer 4/2020 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.